Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.40M | -23.11M | -23.76M | -21.79M | -21.27M |
| Total Depreciation and Amortization | 303.00K | 314.00K | 302.00K | 270.00K | 243.00K |
| Total Amortization of Deferred Charges | 934.00K | 944.00K | 964.00K | 976.00K | 1.00M |
| Total Other Non-Cash Items | 1.23M | 1.16M | 2.45M | 2.08M | 2.79M |
| Change in Net Operating Assets | -597.00K | 159.00K | 1.84M | 857.00K | 1.34M |
| Cash from Operations | -21.53M | -20.54M | -18.20M | -17.61M | -15.90M |
| Capital Expenditure | -178.00K | -173.00K | -179.00K | 527.00K | -88.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -178.00K | -173.00K | -179.00K | 527.00K | -88.00K |
| Total Debt Issued | 0.00 | 5.00M | 10.00M | 15.00M | 22.50M |
| Total Debt Repaid | -879.00K | -902.00K | -927.00K | -949.00K | -866.00K |
| Issuance of Common Stock | 36.92M | 37.10M | 7.10M | 3.05M | 344.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -607.00K | -1.82M | -2.43M | -4.27M |
| Other Financing Activities | 66.00K | 66.00K | 2.28M | 1.54M | 1.82M |
| Cash from Financing | 36.11M | 40.65M | 16.63M | 16.21M | 19.53M |
| Foreign Exchange rate Adjustments | -3.00K | -4.00K | 3.00K | 1.00K | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.39M | 19.94M | -1.74M | -869.00K | 3.54M |